Correlative analysis of U2AF1 mutations with clinical features in MDS patients suggested that patients with U2AF1 mutations had significantly lower hemoglobin percentages when compared with patients with wild-type U2AF1 (p = 0.017; Fig. 1A). Here, U2AF1 is linked to myelodysplastic syndrome.